Table 2.
Overall associations between QoL at baseline (AFEQT) and the occurrence of MACE after 12 months of follow-up (T1)
| Total study population | MACE1 (T1-T0) | ||||
|---|---|---|---|---|---|
| AFEQT score (T0) | n (%) | n (%) | ORminimally−adjusted (95% CI) | ORmv−adjusted (95% CI) | p-value |
| Below median (4.63 to ≤ 75.93) | 339 (49.3%) | 25 (7.4%) | 2.55 (1.23–5.29) | 2.42 (1.16–5.06) | 0.018 |
| Above median (> 75.93 to 100) | 348 (50.7%) | 11 (3.2%) | 1 (ref.) | 1 (ref.) | |
Minimally-adjusted models were adjusted for categorized age (< 65; ≥65) and gender
Multivariable-adjusted models were additionally adjusted for HAS_BLED (0–1; ≥2), CHA2DS2-VASc (0–1; ≥2), type of AF (paroxysmal/persistent)
1 MACE was defined as the composite of any MI/stroke (n=14), heart failure (n=20) and mortality (n=8).